Search

Search Constraints

You searched for: Author/Creator Sweetser, Marianne T.

Search Results

1. Efficacy and safety of givosiran for acute hepatic porphyria: 24‐month interim analysis of the randomized phase 3 ENVISION study. (16th November 2021)

2. EXPLORE B: A prospective, long‐term natural history study of patients with acute hepatic porphyria with chronic symptoms. Issue 6 (18th September 2022)

3. Hyperhomocysteinemia in acute hepatic porphyria (AHP) and implications for treatment with givosiran. (2nd September 2022)

4. Inside Front Cover. (19th January 2022)

5. Issue Cover. (29th December 2021)

6. Patisiran, an RNAi therapeutic for patients with hereditary transthyretin‐mediated amyloidosis: Sub‐analysis in Japanese patients from the APOLLO study. Issue 5 (21st July 2020)

7. Quality of life outcomes in APOLLO, the phase 3 trial of the RNAi therapeutic patisiran in patients with hereditary transthyretin-mediated amyloidosis. (2nd July 2020)

8. S1063 Disease Burden in Patients With Acute Hepatic Porphyria: Experience From the Phase 3 ENVISION Study. (October 2021)

9. S1170 Efficacy and Safety of Givosiran in Patients With Acute Hepatic Porphyria: 24-Month Interim Analysis of the Phase 3 ENVISION Randomized Clinical Trial. (October 2021)

10. S1171 EXPLORE Part B: A Prospective, International, Long-Term Natural History Study of Patients With Acute Hepatic Porphyria With Recurrent Symptoms. (October 2021)